
Varian Medical Systems, Inc. VAR
Varian Medical Systems, Inc. Book Value 2011-2026 | VAR
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Varian Medical Systems, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 66.7 M | 114 M | 53.7 M | 51.6 M | -127 M | -96.3 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 114 M | -127 M | 10.5 M |
Book Value of other stocks in the Medical instruments industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M | ||
|
Becton, Dickinson and Company
BDX
|
55.3 B | $ 154.51 | -1.17 % | $ 44.4 B | ||
|
Luminex Corporation
LMNX
|
199 M | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
76.5 M | - | -9.52 % | $ 20.6 M | ||
|
Repligen Corporation
RGEN
|
1.96 B | $ 117.78 | -0.46 % | $ 6.56 M | ||
|
Antares Pharma, Inc.
ATRS
|
257 M | - | - | $ 955 M | ||
|
Ekso Bionics Holdings
EKSO
|
9.03 M | $ 9.4 | -11.74 % | $ 22.8 M | ||
|
Cantel Medical Corp.
CMD
|
411 M | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
762 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
388 M | - | -0.05 % | $ 10.3 B | ||
|
Haemonetics Corporation
HAE
|
2.45 B | $ 56.83 | 1.05 % | $ 2.86 B | ||
|
ICU Medical
ICUI
|
4.05 B | $ 123.31 | -1.53 % | $ 3.04 B | ||
|
Intuitive Surgical
ISRG
|
17.9 B | $ 452.07 | -2.67 % | $ 161 B | ||
|
Harvard Bioscience
HBIO
|
13.7 M | $ 5.2 | 2.16 % | $ 231 M | ||
|
Isoray
ISR
|
207 M | - | 0.03 % | $ 108 M | ||
|
AngioDynamics
ANGO
|
183 M | $ 10.31 | -13.65 % | $ 421 M | ||
|
Repro Med Systems
KRMD
|
17 M | $ 4.32 | 1.17 % | $ 200 M | ||
|
AtriCure
ATRC
|
492 M | $ 29.07 | 2.68 % | $ 1.39 B | ||
|
Pulse Biosciences
PLSE
|
80.7 M | $ 23.0 | -0.13 % | $ 1.55 B | ||
|
InfuSystem Holdings
INFU
|
48 M | $ 9.29 | -0.11 % | $ 192 M | ||
|
Masimo Corporation
MASI
|
1.05 B | $ 178.59 | 0.33 % | $ 9.52 B | ||
|
iRhythm Technologies
IRTC
|
153 M | $ 116.8 | -1.2 % | $ 3.74 B | ||
|
Merit Medical Systems
MMSI
|
1.58 B | $ 67.7 | -0.78 % | $ 4 B | ||
|
BioLife Solutions
BLFS
|
349 M | $ 19.51 | 1.14 % | $ 899 M | ||
|
electroCore
ECOR
|
-1.71 M | $ 6.8 | 3.03 % | $ 57.7 K | ||
|
STERIS plc
STE
|
6.62 B | $ 218.71 | -0.56 % | $ 21.6 B | ||
|
Teleflex Incorporated
TFX
|
3.12 B | $ 117.81 | -0.52 % | $ 5.26 B | ||
|
Utah Medical Products
UTMD
|
119 M | $ 63.12 | 0.4 % | $ 205 M | ||
|
OraSure Technologies
OSUR
|
341 M | $ 3.08 | 0.98 % | $ 226 M | ||
|
West Pharmaceutical Services
WST
|
3.18 B | $ 254.8 | 0.82 % | $ 18.4 B | ||
|
DENTSPLY SIRONA
XRAY
|
1.34 B | $ 11.63 | -0.26 % | $ 2.32 B | ||
|
Glaukos Corporation
GKOS
|
462 M | $ 112.77 | 0.12 % | $ 5.46 B | ||
|
ResMed
RMD
|
3.36 B | $ 224.09 | 0.56 % | $ 32.7 B | ||
|
Predictive Oncology
POAI
|
47.7 M | - | - | $ 31.1 M | ||
|
Baxter International
BAX
|
6.1 B | $ 16.68 | -0.6 % | $ 8.56 B | ||
|
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | ||
|
STAAR Surgical Company
STAA
|
344 M | $ 20.21 | 4.55 % | $ 1 B | ||
|
Stereotaxis
STXS
|
18.7 M | $ 1.87 | 1.08 % | $ 170 M | ||
|
The Cooper Companies
COO
|
8.24 B | $ 70.17 | -1.76 % | $ 14 B | ||
|
LeMaitre Vascular
LMAT
|
394 M | $ 108.49 | -0.24 % | $ 2.46 B | ||
|
Microbot Medical
MBOT
|
77.6 M | $ 2.4 | 1.27 % | $ 110 M | ||
|
Nephros
NEPH
|
8.36 M | $ 2.87 | -2.21 % | $ 29.8 M | ||
|
Envista Holdings Corporation
NVST
|
5.68 B | $ 25.81 | -0.35 % | $ 4.34 B | ||
|
Milestone Scientific
MLSS
|
2.81 M | $ 0.28 | -4.86 % | $ 23 M | ||
|
Alcon
ALC
|
22 B | $ 74.56 | -1.26 % | $ 40.4 B | ||
|
Pro-Dex
PDEX
|
36.6 M | $ 51.67 | 1.33 % | $ 170 M | ||
|
Retractable Technologies
RVP
|
74.4 M | $ 0.69 | 2.99 % | $ 20.7 M |